In the current study, we first performed dual-IF to examine whether E-selectin/VCAM-1/ICAM-1 (AlexaFluor-488) and KLF4 (Cy-3) show any overlap in their expression profiles on cerebral blood vessels after CIS. The gene discussed is ICAM1; the disease is in situ carcinoma.